Home > EU to sign a deal for 300 million doses of BioNtech/Pfizer vaccine with '90% success rate'

News
EU to sign a deal for 300 million doses of BioNtech/Pfizer vaccine with '90% success rate'

Description

The EU has already signed supply deals with AstraZeneca, Sanofi and Johnson & Johnson for their potential COVID-19 shots.

Added on the 11/11/2020 12:23:19 - Copyright : Euronews EN

To customise your video :

Or Create an account

More videos on the subject

  • Pfizer Makes Deal For 100-Million Doses Of Vaccine

    On Wednesday, Pfizer and BioNTech announced having reached a deal with the U.S. government with an additional 100 million doses by July 31. That's up from the initial 100 million doses ordered already. The deal follows a similar extension of doses reached by the U.S. with Moderna for their vaccine. Both vaccines require two doses to be administered. The $2 billion deal calls for at least an additional 70 million doses to be provided to the U.S. by June 30. The remaining 30 million doses needing to be delivered by July 31. It also allows for the U.S. to obtain up to an additional 400 million doses in the future.

    23/12/2020 - Wochit
  • EU 'to authorise a contract for up to 300 million doses' BioNTech/Pfizer vaccine: chief

    The President of the European Commission Ursula von der Leyen announces that the EU will "authorise a contract for up to 300 million doses of the vaccine developed by BioNTech and Pfizer", in a video published on the Commission's Twitter account. SOUNDBITE

    10/11/2020 - AFPTV - First images
  • EU seals deal with BioNTech/Pfizer for up to 1.8 bn extra vaccine doses: von der Leyen

    The EU has concluded a deal with BioNTech/Pfizer for up to 1.8 billion extra doses of its Covid-19 vaccine, European Commission chief Ursula von der Leyen says at a media conference in Porto, Portugal. SOUNDBITE

    08/05/2021 - AFPTV - First images
  • Pfizer/BioNtech to supply 75 million more vaccine doses to the EU

    Berlin (Germany), Feb 1 (EFE / EPA), (ARCHIVE).- The German company BioNTech announced Monday that it will supply the EU with 75 million doses of its Covid-19 vaccine in the second quarter of the year after optimizing its production process. ARCHIVE FOOTAGE OF BIONTECH HEADQUARTERS IN MAINZ AND VACCINATION CAMPAIGN IN STUTTGART, GERMANY.

    01/02/2021 - EFE Inglés
  • EU doubles BioNTech/Pfizer vaccine pre-order to 600 million doses

    European Commission President Ursula von der Leyen announces that the EU has struck a deal to double its supply of the Pfizer-BioNTech vaccine against Covid-19 to a total 600 million doses. SOUNDBITE

    08/01/2021 - AFPTV - First images
  • Another 100 Million Doses Of COVID-19 Vaccine Bought By US Government

    The US government has ordered another 100 million doses of Moderna's coronavirus vaccine. This brings the total number of vaccines ordered to 200 million, says Business Insider. If the vaccine receives emergency-use authorization from the FDA, Moderna plans to deliver. The delivery will be for 20 million doses by the end of December with the rest over the start of 2021. The US still has the option to purchase another 300 million doses from Moderna. Everyone who wants the vaccine should be able to get one, timing is the main concern.

    12/12/2020 - Wochit

More videosNews

Watch video of  - DemainEntreprendre - épisode 12 - Label : Economie wallonne -
News

DemainEntreprendre - épisode 12

29/04/2021 12:55:32